Índice

• • ·The First New Zealand Experience of Percutaneous Coronary Intervention Without Onsite Cardiac Surgery

    Página :S2

    P Adamson, J Ayling, J Gillespie, J Walker, A Hamer, N Fisher

    
• • ·Christchurch Hospital Experience in PFO Closure

    Página :S2

    S Aldous, R Troughton, J Blake

    
• • ·“Rule Out” Utility of a Cardiac Multimarker Panel in Low Risk Patients

    Página :S3

    S Aldous, M Than

    
• • ·Stress Perfusion Imaging Using Cardiac MRI: The First New Zealand Experience

    Página :S3

    K Allcock, C Edwards, JP Christiansen

    
• • ·Left Ventricular (LV) Geometry in Patients With Type 2 Diabetes: A Cross-Sectional Study of Patients With Type 2 Diabetes (T2DM) in the Community

    Página :S3

    S Bhattacharyya, JB Somaratne, GA Whalley, K Poppe, W Bagg, RN Doughty

    
• • ·An Objective Approach to Haemostasis Following Trans-radial Cardiac Catheterization

    Página :S4

    C Carrington, R Mann, S El Jack

    
• • ·Thrombolysis for Pulmonary Embolism: The Christchurch Experience

    Página :S4

    W Chan, T Campbell, S MacDonald, I Crozier

    
• • ·Long Term Clinical Outcomes of Treatment of In-Stent Restenosis With Drug Eluting Stents

    Página :S5

    S Cherian, C Sebastian, A Puri, M Liang, G Devlin

    
• • ·Nurse-led Outpatient Chest Pain Clinic: Safety and Efficacy

    Página :S5

    KL Chow, L Ball, E Griner, C Edwards, G Armstrong

    
• • ·Quantitative Evaluation of Aortic Regurgitation in Asymptomatic Patients Using Cardiac MRI Predicts Long-Term Outcome

    Página :S5

    JP Christiansen, C Edwards, G Armstrong, H Patel, T Scott, HH Hart

     
• • ·Report on the First Twelve Months Activity of New Zealands First Specialist Cardiac Nurse-led Chest Pain Clinic

    Página :S6

    SM Clayton, NP Lucic, KJ de Bruijn, A Hamer, DE Hampson, CA Johansen, TM Lawson, N Fisher

    
• • ·Assessment of Asymptomatic Heart Murmurs in Adult Outpatients

    Página :S6

    HA Coverdale

    
• • ·The New Zealand Heart Failure Registry: Two Years On

    Página :S7

    GP Devlin, R Troughton, M Lund, R Doughty, on behalf of the NZHFR Investigators

    
• • ·Brain Natriuretic Peptide and Troponin I as Predictors of Right Ventricular Dysfunction and Long Term Adverse Events After Pulmonary Embolism

    Página :S7

    P Ding, SP Wong, P Casey, C Wong, J White, I Zeng, T Sutton

    
• • ·Involvement of a Clinical Pharmacist in the Followup of Outpatient Heart Failure Patients Could Improve Clinical Outcomes

    Página :S8

    A Egan, L Pugliese, N Fisher

    
• • ·Late Stent Thrombosis After Xience Stent Implantation and Six Months of Clopidogrel

    Página :S8

    JM Elliott, S Aldous, J Blake, D McClean, M Richards, D Smyth

    
• • ·Patients With a Family History of Cardiovascular Disease are More Likely to be Above the 90th Percentile of an Age and Sex-matched Population: Potential Benefits of the Calcium Scoring Tool

    Página :S8

    CJ Ellis, C Edwards, ME Legget, N Van Pelt, JA Ormiston, J Christiansen, H. Winch, M. Osborne, G. Gamble

    
• • ·High Calcium Scores in Patients With a Low Framingham Risk of Cardiovascular (CVS) Disease: Implications for More Accurate CVS Risk Assessment

    Página :S9

    CJ Ellis, ME Legget, C Edwards, N Van Pelt, JA Ormiston, J Christiansen, H Winch, M Osborne, G Gamble

     
• • ·Coronary Patients’ Perception of Risk and Future Risk Reduction

    Página :S9

    N Gandhi, S Dean, S Mann

    
• • ·A Single Multidrug Key Performance Indicator for Secondary Prevention in ACS Patients?

    Página :S10

    D Garofalo, JL Looi, AJ Kerr

    
• • ·Rapid Pharmacogenetic Testing for Clopidogrel Using the INFINITI Analyser: A Dose Escalation Study

    Página :S10

    PA Gladding, MW Webster, J Ormiston, J Stewart, P Ruygrok, K Fu, R Baak

    
• • ·Higher Allelic Frequency of Variants at the 9p21 Locus in Maori and Pacific Islanders Presenting With Severe Coronary Artery Disease

    Página :S11

    PA Gladding, I Zeng, M Shanthakumar, R Stewart, M Webster, H White, V Cameron, K Ellis

    
• • ·A Simulation of Warfarin Maintenance Dose Requirement Using a Pharmacogenomic Algorithm in an Ethnically Diverse Cohort

    Página :S11

    PA Gladding, R Stewart, M Webster, H White

    
• • ·Percutaneous Coronary Intervention in a Tertiary Hospital Without on Site Cardiosurgical Backup—Is it Safe?

    Página :S11

    T Glenie, D Scott, IP Kay

    
• • ·Bleeding Events in Patients Randomised to Mobilise 4 or 6 h After Percutaneous Coronary Intervention (PCI)

    Página :S12

    C Harris, M Hart, D Smyth, JM Elliott, M Richards, J Blake, C Bycroft

    
• • ·Effectiveness of MPatcH on Haemostasis and Mobilisation Following Diagnostic and Interventional Cardiology Procedures

    Página :S12

    M Hart, C Harris, D Smyth, JM Elliott, M Richards, J Blake, C Bycroft

    
• • ·Time to First Therapy From Implantable Cardioverter-Defibrillators: Primary Versus Secondary Indications

    Página :S13

    P Jogia, S Heald, R Allen, M Stiles

    
• • ·Implantable Cardioverter-Defibrillators: 4 year Experience at a Single Centre. How do we Compare?

    Página :S13

    P Jogia, S Heald, R Allen, M Stiles

    
• • ·Transapical Aortic Valve Implantation: Waikato Experience

    Página :S13

    N Kejriwal, G Devlin, R Fisher, S Pasupati

    
• • ·The Heart Forecast Tool-Integrating Absolute, Relative Risk and Long-Term CVD Risk to Support Risk Communication and Behaviour Change

    Página :S14

    AJ Kerr, S Wells, S Eadie, A McLachlan, C Wiltshire, R Jackson

    
• • ·Underestimation of Aortic Flow by Phase Contrast in Aortic Stenosis by Contemporary CMR—Implications for Aortic Valve Area Assessment

    Página :S14

    AJ Kerr, K O’Brien, R Gabriel, B Cowan, A Young

    
• • ·Not All Troponin Positive Non-ST-Elevation Acute Coronary Syndromes (NSTEACS) Require Angiography: Assessment of Midland Regional Guidelines

    Página :S15

    B Killion, M Liang, P Jogia, A Puri, G Devlin

    
• • ·Management of Acute Coronary Syndromes in New Zealand: The Midland Experience

    Página :S15

    B Killion, P Jogia, M Liang, G Devlin

    
• • ·HVDHB Heart Failure Audit (September–December 2007)

    Página :S15

    W Kong, T O’ Meeghan, K Ferrier, R Anscombe, J Dewar, M Hawkins

    
• • ·Comparison of Primary Percutaneous Coronary Intervention With Thrombolytic Therapy for ST Elevation Myocardial Infarction in Dunedin Hospital 2007

    Página :S16

    HJ Kwon, VHT Chen, GT Wilkins, MJA Williams

    
• • ·Are Failed ICD Shocks Due to Changing Ventricular Fibrillation Characteristics?

    Página :S16

    P Larsen, N Lever

    
• • ·Percutaneous Aortic Valve Replacement Using The Corevalve^® Revalving System For Severe Aortic Stenosis (AS)—Initial Mercy Hospital Experience

    Página :S17

    ME Legget, JA Ormiston, JT Stewart, MWI Webster, C Kruger, N Middleton, PJ Raudkivi, DA Haydock

    
• • ·Primary Angioplasty For Definite Stent Thrombosis: The Waikato Experience

    Página :S17

    M Liang, A Puri, K Abercrombie, S McAllister, G Devlin

    
• • ·Left Ventricular Dysfunction in Patients Presenting With Acute Atrial Fibrillation: The Importance of Rate-Related Cardiomyopathy

    Página :S17

    C Lin, C Edwards, G Armstrong, H Patel, T Scott, HH Hart, JP Christiansen

    
• • ·Prognostic Value of Myocardial Stress Perfusion Imaging in Patients With Existing Coronary Disease

    Página :S18

    C Lin, K Smidt, JP Christiansen

     
• • ·Implementation of an Evidence-Based Protocol for DC Cardioversion Improves Quality of Patient Care and Influences Outcomes

    Página :S18

    K-L Looi, A Ng, G Armstrong, C Edwards, H Patel, T Scott, HH Hart, JP Christiansen

    
• • ·Dobutamine Stress Echocardiography in Post-Recovery Apical Ballooning Syndrome

    Página :S19

    JL Looi, A Khan, A To, S Takau, RAH Stewart, AJ Kerr

    
• • ·Anonymised Electronic Tracking of ACS Patient Outcome and Linkage to CVD Risk Factors in South Auckland: Proof of Concept

    Página :S19

    JL Looi, A McLachlan, M Lee, R Pylypchuk, AJ Kerr

    
• • ·Major Delays Experienced by Patients Waiting for In-Hospital Cardiac Angiography and Coronary Artery Bypass Graft Surgery Result in Significant Extra Health Care Costs

    Página :S20

    KL Looi, KL Chow, JL Looi, S Haliday, M Lee, G Gamble, HD White, CJ Ellis

     
• • ·Use of Secondary Prevention Medication Before and After an Acute Coronary Syndrome: Potential Long-Term Community Improvements, But Is This as ‘Good as it Gets’ After Hospital Discharge?

    Página :S21

    JL Looi, KL Looi, KL Chow, S Haliday, M Lee, G Gamble, HD White, CJ Ellis

    
• • ·The Gold Standard: 30 Day and 1 Year Mortality in Patients Aged 80 Years or More Undergoing Isolated Aortic Valve Replacement Surgery in New Zealand

    Página :S21

    B Mahon, S Watson, R Naden

    
• • ·Excess Winter Cardiovascular Mortality And Morbidity in New Zealand is Seen in All Disease Subcategories

    Página :S21

    S Mann, M Baker, S Hales, V Kamalesh, L Telfar Barnard, J Zhang, P Howden-Chapman

    
• • ·Coronary Heart Disease Incidence, Prevalence and Survival Among The Maori Population, 2000–2002

    Página :S22

    S Mann, M Tobias, L Yeh, C Wright, T Riddell, W Chan, R Jackson

    
• • ·Plasma Myeloperoxidase at the Culprit Coronary Lesion in Acute Myocardial Infarction

    Página :S22

    CJ Marshall, M Nallaratnam, T Mocatta, D Smyth, AM Richards, JM Elliott, J Blake, C Winterbourn, AJ Kettle, DR McClean

    
• • ·Trans-Cardiac Production of Urotensin II in Acute and Chronic Ischaemia

    Página :S23

    CJ Marshall, S Fisher, TG Yandle, D Smyth, JM Elliott, J Blake, AM Richards, DR McClean

    
• • ·Barriers to ICD Therapy: Clinicians Perceptions are Important

    Página :S23

    B McHale, S Harding, N Lever, P Larsen

    
• • ·Assessment of a Nurse-led Cardiovascular Disease Risk Management Intervention For Patients With Gout

    Página :S23

    A McLachlan, N Dalbeth, M Lee, AJ Kerr

    
• • ·Viability Assessment Using Cardiac MRI is an Important Factor in The Decision to Revascularise Patients with Ischaemic Cardiomyopathy

    Página :S24

    D Oh, C Edwards, JP Christiansen

    
• • ·Does a Nurse Practitioner Clinic for Heart Failure Patients Make a Difference?

    Página :S24

    CB O’Sullivan

    
• • ·Early Experience With Transcatheter Aortic Valve Insertion [TAVI] Via Transarterial Approach in a New Zealand Public Hospital

    Página :S24

    S Pasupati, G Devlin, R Fisher, R Linder, M Liang, N Kejriwal

    
• • ·Prediction of Global Left Ventricular Functional Recovery in Patients with Heart Failure Undergoing Surgical Revascularization, Based on the Number of Viable Segments Assessed by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance

    Página :S25

    T Pegg, J Joslin, J Francis, T Karamitsos, E Dall’Armellina, K Smith, DP Taggart, S Neubauer, J Selvanayagam

    
• • ·Defining Myocardial Injury and Function Following Coronary Artery Bypass Grafting: Insights from Serial Cardiovascular Magnetic Resonance Imaging and Biochemical Assessment

    Página :S25

    T Pegg, Z Maunsell, T Karamitsos, R Taylor, T James, J Francis, D Taggart, S Neubauer, J Selvanayagam

    
• • ·Untreated Severe Aortic Stenosis (AS) is Associated with Poor Outcomes

    Página :S26

    S Perera, N Wijesinghe, E Ly, G Devlin, S Pasupati

    
• • ·Role of Angiographic Perfusion Score to Predict Clinical Outcomes in ACS Patients Undergoing PCI

    Página :S26

    A Puri, L Fischer, R Sethi, SK Dwivedi, VS Narain, RK Saran, VK Puri

    
• • ·Fractional Flow Reserve and Long Term Outcomes in the Real World

    Página :S26

    A Puri, S Perera, K Abercrombie, G Devlin

    
• • ·Half the ACS Patients Admitted to Middlemore CCU have a Dysglycaemic Syndrome

    Página :S27

    NPP Quek, AJ Kerr, I Zeng, J Baker, AM Dissanayake

    
• • ·Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Auckland Experience

    Página :S27

    M Ratnayake, R Garg, S Greaves, I Gerber, M Webster

    
• • ·Endovascular Aortic Arch Repair after Aortic Arch Debranching for Acute Dissection

    Página :S27

    P Singhal, MJ Hamilton, V Vasudevan, R Kejriwal, S Muthukumarswamy, NK Kejriwal

    
• • ·Screening for Cardiovascular Disease using Hand-carried Echocardiography in Asymptomatic Primary Care Patients with Type 2 Diabetes Mellitus

    Página :S28

    JB Somaratne, RN Doughty, KK Poppe, W Bagg, GA Whalley

    
• • ·Do Calcium Supplements Lead to an Increase in Coronary Calcification?

    Página :S28

    N Van Pelt, P Ruygrok, MJ Bolland, GD Gamble, B Mason, R Ames, IR Reid

    
• • ·Use of a Modern Imaging Protocol for 64-Slice Ct Cardiac Angiography Results in a Significant Reduction in the Radiation Dose Received by Patients

    Página :S29

    N Van Pelt, CJ Ellis, ME Legget, C Edwards, JA Ormiston, J Christiansen, H Winch, M Osborne, G Gamble

     
• • ·Normal Coronary Arteries in Troponin-positive Patients

    Página :S30

    MR Webber, MB Simmonds

    
• • ·Levosimendan: Who, When and Why at Middlemore Hospital

    Página :S30

    J White, M Lund, T Sutton

    
• • ·The Absence of Stress in Patients with “Stress Cardiomyopathy”

    Página :S30

    C Wong, A Khan, J Looi, I Zeng, AJ Kerr